The company has outstanding warrants to management and the board of directors of 2,500,000 and to employees of Psyros Diagnostics Ltd. of 7,310,000, which can result in a total of 9,810,000 shares and can thus cause dilution.
Prolight Diagnostics’ share is traded on the Nordic Growth Market, NGM SME, under the name PRLD.